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From the very earliest days of malaria research and control
it has been recognised that attacking the mosquito vectors
is one of the most powerful interventions at our disposal.
Recognising that these activities are, sensu stricto, attack-
ing the population of parasites as they pass through the
vectors, it is now appreciated that attacking the parasite
per se within the mosquito vector has equal potential to
contribute to malaria control, elimination or indeed
eradication.
The rationale behind current anti-parasitic malaria
transmission-blocking strategies is profound. Parasite
populations in the mosquito host can be 10–10 smaller
than those in the human host, offering reduced genetic/
molecular potential with which the parasite can combat
any intervention. Further, the parasites are, for the first 24
hours, extracellular and directly exposed to any interven-
tion (drug; vaccine or other) delivered in the infectious
bloodmeal. Finally, within the vector many of the accessi-
ble parasite and mosquito surface molecules have never
been exposed to the human immune system, perhaps as a
correlate to this they, by comparison with merozoite and
sporozoite surface molecules, are neither antigenically var-
iant, nor significantly polymorphic, thus offering stable
and geographically widespread targets for intervention.
In response to the new calls for research to underpin
possible elimination/eradication campaigns, current
efforts are now describing potential and effective new
drugs and vaccine strategies targeting the parasites in the
mosquito bloodmeal. Recent studies examining the
potency of transmission blocking vaccine candidates, and
the identification of new and transmission blocking drugs
will be reviewed. Questions must be asked as to what
relevance the outputs of current laboratory based trans-
mission blocking experiment have to the key population-
based parameters that must be measured in the field.
As an example:- If an intervention causes a 50% reduc-
tion in oocyst number in a laboratory population of mos-
quitoes, what impact, if any, will it have on the number
of secondary cases in the field? Recent studies addressing
these key questions will be reported.
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